Regulation of AKR1B1 by thyroid hormone and its receptors

Molecular and Cellular Endocrinology

Volumn 307, Issue 1-2, 2009, Pages 109-117

  Liao, Chen Shin ^a   Tai, Pei Ju ^a   Huang, Ya Hui ^a   Chen, Ruey Nan ^a   Wu, Sheng Ming ^a   Kuo, Lu Wei ^a   Yeh, Chau Ting ^b,c   Tsai, Ming Ming ^d   Chen, Wei Jan ^c   Lin, Kwang Huei ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

AKR1B1; Receptor; Thyroid hormone

Indexed keywords

ALDEHYDE REDUCTASE; COMPLEMENTARY DNA; LIOTHYRONINE; LIOTHYRONINE RECEPTOR; MESSENGER RNA; THYROID HORMONE; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL STRAIN HEPG2; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA MICROARRAY; ENZYME REGULATION; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROIDECTOMY; UPREGULATION;

ALDEHYDE REDUCTASE; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLOHEXIMIDE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; PROTEIN BINDING; RATS; RESPONSE ELEMENTS; RNA, MESSENGER; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA; TRANSCRIPTION, GENETIC; TRIIODOTHYRONINE;

EID: 67349236706     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.04.013     Document Type: Article

References (33)

1. Aida K., Ikegishi Y., Chen J., Tawata M., Ito S., Maeda S., and Onaya T. Disruption of aldose reductase gene (Akr1b1) causes defect in urinary concentrating ability and divalent cation homeostasis. Biochem. Biophys. Res. Commun. 277 (2000) 281-286
2. Chang Q., Harter T.M., Rikimaru L.T., and Petrash J.M. Aldo-keto reductases as modulators of stress response. Chem. Biol. Interact. 143-144 (2003) 325-332
3. Chen R.N., Huang Y.H., Lin Y.C., Yeh C.T., Liang Y., Chen S.L., and Lin K.H. Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines. Endocrinology 149 (2008) 3817-3831
4. Chen R.N., Huang Y.H., Yeh C.T., Liao C.H., and Lin K.H. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma. Cancer Res. 68 (2008) 1697-1706
5. Chopra I.J., Wu S.Y., Teco G.N., and Santini F. A radioimmunoassay for measurement of 3,5,3′-triiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life. J. Clin. Endocrinol. Metab. 75 (1992) 189-194
6. Donaghue K.C., Margan S.H., Chan A.K., Holloway B., Silink M., Rangel T., and Bennetts B. The association of aldose reductase gene (AKR1B1) polymorphisms with diabetic neuropathy in adolescents. Diabet. Med. 22 (2005) 1315-1320
7. Fukumoto S., Yamauchi N., Moriguchi H., Hippo Y., Watanabe A., Shibahara J., Taniguchi H., Ishikawa S., Ito H., Yamamoto S., Iwanari H., Hironaka M., Ishikawa Y., Niki T., Sohara Y., Kodama T., Nishimura M., Fukayama M., Dosaka-Akita H., and Aburatani H. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin. Cancer Res. 11 (2005) 1776-1785
8. Gallego O., Ruiz F.X., Ardevol A., Dominguez M., Alvarez R., de Lera A.R., Rovira C., Farres J., Fita I., and Pares X. Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 20764-20769
9. Huang Y.H., Lee C.Y., Tai P.J., Yen C.C., Liao C.Y., Chen W.J., Liao C.J., Cheng W.L., Chen R.N., Wu S.M., Wang C.S., and Lin K.H. Indirect regulation of human dehydroepiandrosterone sulfotransferase family 1A member 2 by thyroid hormones. Endocrinology 147 (2006) 2481-2489
10. Huang Y.H., Tsai M.M., and Lin K.H. Thyroid hormone dependent regulation of target genes and their physiological significance. Chang Gung Med. J. 31 (2008) 325-334
11. Koenig R.J. Thyroid hormone receptor coactivators and corepressors. Thyroid 8 (1998) 703-713
12. Lazar M.A. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr. Rev. 14 (1993) 184-193
13. Lefrancois-Martinez A.M., Bertherat J., Val P., Tournaire C., Gallo-Payet N., Hyndman D., Veyssiere G., Bertagna X., Jean C., and Martinez A. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 89 (2004) 3010-3019
14. Li C.P., Goto A., Watanabe A., Murata K., Ota S., Niki T., Aburatani H., and Fukayama M. AKR1B10 in usual interstitial pneumonia: expression in squamous metaplasia in association with smoking and lung cancer. Pathol. Res. Pract. 204 (2008) 295-304
15. Lin K.H., Wang W.J., Wu Y.H., and Cheng S.Y. Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor. Endocrinology 143 (2002) 467-475
16. Ma J., Yan R., Zu X., Cheng J.M., Rao K., Liao D.F., and Cao D. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J. Biol. Chem. 283 (2008) 3418-3423
17. Nagaya T., Nomura Y., Fujieda M., and Seo H. Heterodimerization preferences of thyroid hormone receptor alpha isoforms. Biochem. Biophys. Res. Commun. 226 (1996) 426-430
18. Nishi N., Shoji H., Miyanaka H., and Nakamura T. Androgen-regulated expression of a novel member of the aldo-keto reductase superfamily in regrowing rat prostate. Endocrinology 141 (2000) 3194-3199
19. Privalsky M.L. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu. Rev. Physiol. 66 (2004) 315-360
20. Qiu L., Wu X., Chau J.F., Szeto I.Y., Tam W.Y., Guo Z., Chung S.K., Oates P.J., Chung S.S., and Yang J.Y. Aldose reductase regulates hepatic peroxisome proliferator-activated receptor alpha phosphorylation and activity to impact lipid homeostasis. J. Biol. Chem. 283 (2008) 17175-17183
21. Samuels H.H., Forman B.M., Horowitz Z.D., and Ye Z.S. Regulation of gene expression by thyroid hormone. J. Clin. Invest. 81 (1988) 957-967
22. Scuric Z., Stain S.C., Anderson W.F., and Hwang J.J. New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. Hepatology 27 (1998) 943-950
23. Shih C.H., Chen S.L., Yen C.C., Huang Y.H., Chen C.D., Lee Y.S., and Lin K.H. Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 145 (2004) 2804-2814
24. Tai P.J., Huang Y.H., Shih C.H., Chen R.N., Chen C.D., Chen W.J., Wang C.S., and Lin K.H. Direct regulation of androgen receptor-associated protein 70 by thyroid hormone and its receptors. Endocrinology 148 (2007) 3485-3495
25. Takahashi M., Fujii J., Miyoshi E., Hoshi A., and Taniguchi N. Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes. Int. J. Cancer 62 (1995) 749-754
26. Tammali R., Ramana K.V., Singhal S.S., Awasthi S., and Srivastava S.K. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res. 66 (2006) 9705-9713
27. Weiss R.E., and Ramos H.E. Thyroid hormone receptor subtypes and their interaction with steroid receptor coactivators. Vitam. Horm. 68 (2004) 185-207
28. Wians Jr. F.H., Jacobson J.M., Dev J., Heald J.I., and Ortiz G. Thyrotroph function assessed by sensitive measurement of thyrotropin with three immunoradiometric assay kits: analytical evaluation and comparison with the thyroliberin stimulation test. Clin. Chem. 34 (1988) 568-575
29. Yan R., Zu X., Ma J., Liu Z., Adeyanju M., and Cao D. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention. Int. J. Cancer 121 (2007) 2301-2306
30. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81 (2001) 1097-1142
31. Yoshitake H., Takahashi M., Ishikawa H., Nojima M., Iwanari H., Watanabe A., Aburatani H., Yoshida K., Ishi K., Takamori K., Ogawa H., Hamakubo T., Kodama T., and Araki Y. Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int. J. Gynecol. Cancer 17 (2007) 1300-1306
32. Zeindl-Eberhart E., Haraida S., Liebmann S., Jungblut P.R., Lamer S., Mayer D., Jager G., Chung S., and Rabes H.M. Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas. Hepatology 39 (2004) 540-549
33. Zhang J., and Lazar M.A. The mechanism of action of thyroid hormones. Annu. Rev. Physiol. 62 (2000) 439-466